Casteleijn FM - Search Results

1

How cure rates drive patients' preference for urethral bulking agent or mid-urethral sling surgery as therapy for stress urinary incontinence.

Casteleijn FM, Enklaar RA, El Bouyahyaoui I, Jeffery S, Zwolsman SE, Roovers JWR. Casteleijn FM, et al. Neurourol Urodyn. 2019 Jun;38(5):1384-1391. doi: 10.1002/nau.23997. Epub 2019 Apr 15. Neurourol Urodyn. 2019. PMID: 30989703

2

Are patients willing to trade cure rate against less pain? Patients' preferences for single incision midurethral sling or transobturator standard midurethral sling.

Schellart RP, Casteleijn FM, Dijkgraaf MGW, Tutolo M, Roovers JWR. Schellart RP, et al. Among authors: casteleijn fm. Neurourol Urodyn. 2017 Apr;36(4):1187-1193. doi: 10.1002/nau.23093. Epub 2016 Aug 26. Neurourol Urodyn. 2017. PMID: 27564322

3

Results of an innovative bulking agent in patients with stress urinary incontinence who are not optimal candidates for mid-urethral sling surgery.

Kowalik CR, Casteleijn FM, van Eijndhoven HWF, Zwolsman SE, Roovers JWR. Kowalik CR, et al. Among authors: casteleijn fm. Neurourol Urodyn. 2018 Jan;37(1):339-345. doi: 10.1002/nau.23299. Epub 2017 Apr 28. Neurourol Urodyn. 2018. PMID: 28452427

4

Patients' perspectives on urethral bulk injection therapy and mid-urethral sling surgery for stress urinary incontinence.

Casteleijn FM, Zwolsman SE, Kowalik CR, Roovers JPWR. Casteleijn FM, et al. Int Urogynecol J. 2018 Sep;29(9):1249-1257. doi: 10.1007/s00192-018-3644-0. Epub 2018 Apr 19. Int Urogynecol J. 2018. PMID: 29675556 Free PMC article.

5

Patients' satisfaction and safety of bulk injection therapy Urolastic for treatment of stress urinary incontinence: A cross-sectional study.

Casteleijn FM, Kowalik CR, Berends C, Blaganje M, Lasić Pecev M, van der Linden E, Zwolsman SE, Roovers JWR, Minnee P. Casteleijn FM, et al. Neurourol Urodyn. 2020 Aug;39(6):1753-1763. doi: 10.1002/nau.24417. Epub 2020 Jun 11. Neurourol Urodyn. 2020. PMID: 32526063 Free PMC article.

6

Imaging findings of vinyl dimethyl polydimethylsiloxane used as a paraurethral injectable for female stress urinary incontinence.

de Vries AM, Casteleijn FM, Roovers JWR, Heesakkers JPFA, Fütterer JJ. de Vries AM, et al. Among authors: casteleijn fm. Ther Adv Urol. 2021 Dec 5;13:17562872211060909. doi: 10.1177/17562872211060909. eCollection 2021 Jan-Dec. Ther Adv Urol. 2021. PMID: 35173814 Free PMC article.

7

Sexual Function Following Treatment for Stress Urinary Incontinence With Bulk Injection Therapy and Mid-Urethral Sling Surgery.

Latul YP, Casteleijn FM, Zwolsman SE, Roovers JWR. Latul YP, et al. Among authors: casteleijn fm. J Sex Med. 2022 Jul;19(7):1116-1123. doi: 10.1016/j.jsxm.2022.03.620. Epub 2022 May 12. J Sex Med. 2022. PMID: 35568668 Free article.

8

Cost-effectiveness of urethral bulking polydimethylsiloxane-Urolastic® compared with mid-urethral sling surgery for stress urinary incontinence: A two-arm cohort study.

Casteleijn FM, de Vries AM, Tu LM, Heesakkers JPFA, Latul Y, Kowalik CR, van Eijndhoven HWF, van Eekelen R, Roovers JWR. Casteleijn FM, et al. BJOG. 2023 May;130(6):674-683. doi: 10.1111/1471-0528.17396. Epub 2023 Feb 15. BJOG. 2023. PMID: 36660885

9

[No title available]

[No authors listed] [No authors listed] PMID: 37057544

10

A Clinical Learning Curve Study of Polydimethylsiloxane Urolastic for Stress Urinary Incontinence: Does Safety Improve when Expertise Grow?

Casteleijn F, Latul Y, van Eekelen R, Roovers JP. Casteleijn F, et al. Gynecol Obstet Invest. 2023;88(4):240-248. doi: 10.1159/000530666. Epub 2023 May 16. Gynecol Obstet Invest. 2023. PMID: 37231857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters